SCHEMBL9670236

SCHEMBL9670236

Brc1ccc2c(c1)Nc1ccccc1S2

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOX1 Q9Y5S8 11/20 0.65
MAPT P10636 7/20 0.65
GAA P10253 6/20 0.65
MEN1 O00255 4/20 0.65
KMT2A Q03164 4/20 0.65
SNCA P37840 4/20 0.65
ALOX15 P16050 3/20 0.65
TDP1 Q9NUW8 3/20 0.65
BCHE P06276 2/20 0.65
ACHE P22303 2/20 0.65
CYP1A2 P05177 1/20 0.65
POLB P06746 1/20 0.65
CYP3A4 P08684 1/20 0.65
ADORA3 P0DMS8 1/20 0.65
ALOX12 P18054 1/20 0.65
MAOA P21397 1/20 0.65
CNR1 P21554 1/20 0.65
PTGS1 P23219 1/20 0.65
SLC6A2 P23975 1/20 0.65
HTR2C P28335 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28407357 0.90 SNCA (0.47) NOX1MAPTGAAMEN1KMT2A
SCHEMBL30769565 0.89 NOX1 (0.65) NOX1MAPTGAAMEN1KMT2A
SCHEMBL239782 0.89 NOX1 (0.65) NOX1MAPTGAAMEN1KMT2A
SCHEMBL30065446 0.86 SNCA (0.58) NOX1MAPTGAAMEN1KMT2A
SCHEMBL205578 0.86 SNCA (0.58) NOX1MAPTGAAMEN1KMT2A
Phenothiazine SCHEMBL29349533 0.81 NOX1 (1.00) NOX1MAPTGAAMEN1KMT2A
Phenothiazine SCHEMBL6315328 0.81 NOX1 (1.00) NOX1MAPTGAAMEN1KMT2A
Phenothiazine SCHEMBL9114 0.81 NOX1 (1.00) NOX1MAPTGAAMEN1KMT2A
Phenothiazine SCHEMBL29352248 0.81 NOX1 (1.00) NOX1MAPTGAAMEN1KMT2A
Phenothiazine SCHEMBL2504207 0.81 NOX1 (1.00) NOX1MAPTGAAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12502661-B2 Catalysts for synthesizing cyclic carbonates, preparation methods and uses thereof ANHUI CONCH MATERIAL TECHNOLOGY CO., LTD. (CN) 2025-12-23 US disclosed
US-20250352989-A1 CATALYSTS FOR SYNTHESIZING CYCLIC CARBONATES, PREPARATION METHODS AND USES THEREOF ANHUI CONCH MATERIAL TECH CO LTD (CN) 2025-11-20 US disclosed
CN-119707864-A Compound, luminescent layer main body material and organic electroluminescent device 北京师范大学 2025-03-28 CN disclosed
WO-2024214816-A1 PHOTOSENSITIVE RESIN LAMINATE AND METHOD FOR FORMING RESIST PATTERN 旭化成株式会社 2024-10-17 WO disclosed
CN-118179610-B Catalyst for synthesizing cyclic carbonate, preparation method and application thereof 安徽海螺材料科技股份有限公司 2024-07-16 CN disclosed
CN-118179610-A Catalyst for synthesizing cyclic carbonate, preparation method and application thereof 安徽海螺材料科技股份有限公司 2024-06-14 CN disclosed
CN-111747892-B Thermal activation delayed fluorescent material and electroluminescent device 深圳大学 2022-06-03 CN disclosed
CN-111747892-A Thermal activation delayed fluorescent material and electroluminescent device 深圳大学 2020-10-09 CN disclosed
EP-0163551-B1 PHENOTHIAZINE COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1992-08-12 EP disclosed
EP-0117302-B1 PHENOTHIAZINE DERIVATIVES THE WELLCOME FOUNDATION LIMITED (GB) 1990-06-27 EP disclosed
US-4705854-A ANTIALLERGENS, ANTIHISTAMINES BURROUGHS WELLCOME CO. (US) 1987-11-10 US disclosed
EP-0163551-A1 Phenothiazine compounds THE WELLCOME FOUNDATION LIMITED (GB) 1985-12-04 EP disclosed
EP-0117302-A2 Phenothiazine derivatives THE WELLCOME FOUNDATION LIMITED (GB) 1984-09-05 EP disclosed
US-4115571-A DIURETICS, SMOOTH MUSCLE RELAXANTS, ANTITHROMBOGENIC AGENTS MEAD JOHNSON & COMPANY (US) 1978-09-19 US disclosed
US-4077959-A DIURETICS, SMOOTH MUSCLE RELAXANTS, ANTITHROMBOGENIC MEAD JOHNSON & COMPANY (US) 1978-03-07 US disclosed
US-4021552-A TRANQUILIZERS A. H. ROBINS COMPANY, INCORPORATED (US) 1977-05-03 US disclosed
US-3946004-A DIURETICS, MUSCLE RELAXANTS, ANTITHROMBOGENIC AGENTS MEAD JOHNSON & COMPANY (US) 1976-03-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250352989-A1 CATALYSTS FOR SYNTHESIZING CYCLIC CARBONATES, PREPARATION METHODS AND USES THEREOF PBRM1, POLL, PPOX NOX1 2100/4885MAPT 928/4885GAA 648/4885
US-12502661-B2 Catalysts for synthesizing cyclic carbonates, preparation methods and uses thereof PBRM1, POLL, PPOX NOX1 2100/4885MAPT 928/4885GAA 648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.